NEW ARTICLE ON TREATING CHOLERA WITH ONE OF THE APD'S | Akthelia

Febrile neutropenia is a common,
life-threatening
complication of chemotherapy
Gut barrier Injury and Neutrophil
depletion puts patients at risk for
bacteremia and sepsis
AKTHELIA'S DRUG CANDIDATE KNOCKS OUT
BACTERAEMIA BY STRENGTHENING
INNATE GUT BARRIER DEFENSES
eliminating the need for prophylactiC antibiotics
reducing risk of serious adverse events,
antimicrobial resistance and
microbiome dysbiosis

NEW ARTICLE ON TREATING CHOLERA WITH ONE OF THE APD'S

June 15, 2017

Sarker P, Banik A, Stromberg R, Gudmundsson GH, Raqib R, Agerberth B. 2017. Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia. Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02570-16. doi:10.1128/AAC.02570-16. Print 2017 Jul. PMID: 28438947